Progress of Application of Shenshuaining Capsule Combined with Losar-tan Potassium in Chronic Glomerulonephritis
Chronic glomerulonephritis,also known as chronic nephritis,belongs to the chronic progressive diseases in renal diseases,which will lead to the gradual loss of renal function.In recent years,the application of Shenshuaining capsule combined with losartan potassium has demonstrated excellent results in clinical treatment,and this dosing regimen not only improved the clinical symptoms of patients,but also significantly reduced the Chinese medicine evi-dence points,which provides a new reference path for the treatment of chronic glomerulonephritis.Shenshuaining cap-sule is a kind of Chinese patent medicine with diuretic and antihypertensive effects,while losartan potassium is a kind of drug that can block the binding of angiotensin Ⅱ and its receptor,which has the effect of lowering the blood pres-sure.The combined application of the two drugs can effectively reduce blood pressure and improve renal function,thus reducing the damage to the kidneys caused by chronic glomerulonephritis.As the application of combined drugs is also further developed in the latest research,more and more studies have shown that the combined application of the above drugs can significantly improve renal function and reduce the incidence of urinary protein and hematuria,thus providing better therapeutic effects for patients.Therefore,it is of great significance to analyze the effect of Shens-huaining capsule combined with losartan potassium in the treatment of chronic glomerulonephritis.
万方数据
维普
